Disclosed is a humanized anti-human .alpha. 9-integrin antibody havingimproved activities and/or physical propertiescompared with a donor mouse anti-human .alpha. 9-integrin antibody.Specifically disclosed are: a humanized anti-human .alpha. 9-integrinantibody having a heavy-chain variable region comprising the amino acidsequence depicted in SEQ ID NO: 11 and a light-chainvariable region comprising the amino acid sequence depicted in SEQ ID NO: 17;a humanized anti-human .alpha. 9-integrin antibodyhaving a heavy-chain variable region comprising the amino acid sequencedepicted in SEQ ID NO: 13 and a light-chain variableregion comprising the amino acid sequence depicted in SEQ ID NO: 17; and ahumanized anti-human .alpha. 9-integrin antibody havinga heavy-chain variable region comprising the amino acid sequence depicted inSEQ ID NO: 15 and a light-chain variable regioncomprising the amino acid sequence depicted in SEQ ID NO:9. Also disclosed isa means for preventing or treating a disease ofwhich human .alpha. 9-integrin is involved in the development of the diseasecondition, which utilizes the antibody.